Successfully recruited a EU5 + US HCP study on the topic of Ovarian Cancer. This included multiple nested subquotas on specialty (GYN Onc verses Hem/Med Onc), as well as practice setting and private verses public institutions. SHC’s expertise and consultative help was critical in the identification of several areas of questionnaire changes to align with specific market needs, leading to a successful fielding outcome.